相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties
James M. Murphy et al.
BIOCHEMICAL JOURNAL (2014)
The JH2 domain and SH2-JH2 linker regulate JAK2 activity: A detailed kinetic analysis of wild type and V617F mutant kinase domains
Arturo Sanz Sanz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
被撤回的出版物: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase (Retracted article. See vol. 24, pg. 917, 2017)
Peter Littlefield et al.
CHEMISTRY & BIOLOGY (2014)
Recently targeted kinases and their inhibitors - the path to clinical trials
Stefan Knapp et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
Yibing Shan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
Patrick J. Lupardus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Analysis of steady-state Forster resonance energy transfer data by avoiding pitfalls: Interaction of JAK2 tyrosine kinase with N-methylanthraniloyl nucleotides
Yashavanthi Niranjan et al.
ANALYTICAL BIOCHEMISTRY (2013)
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Angela V. Toms et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
JAK/STAT signaling in hematological malignancies
W. Vainchenker et al.
ONCOGENE (2013)
Comprehensive review of JAK inhibitors in myeloproliferative neoplasms
Mohamad Bassam Sonbol et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson et al.
NATURE MEDICINE (2012)
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
Rajintha M. Bandaranayake et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
Rita Andraos et al.
CANCER DISCOVERY (2012)
Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK) CROSS-VALIDATION OF THE PSEUDOKINASE
Koichi Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
Daniela Ungureanu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
The Constitutive Activation of Jak2-V617F Is Mediated by a π Stacking Mechanism Involving Phenylalanines 595 and 617
Kavitha Gnanasambandan et al.
BIOCHEMISTRY (2010)
JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors
Alexandra Dusa et al.
PLOS ONE (2010)
Integrin-linked kinase is an adaptor with essential functions during mouse development
Anika Lange et al.
NATURE (2009)
PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity
Angus J. M. Cameron et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
Elton Zeqiraj et al.
SCIENCE (2009)
Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site
Eric D. Scheeff et al.
STRUCTURE (2009)
ATP and MO25 alpha Regulate the Conformational State of the STRAD alpha Pseudokinase and Activation of the LKB1 Tumour Suppressor
Elton Zeqiraj et al.
PLOS BIOLOGY (2009)
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt et al.
BLOOD (2008)
Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F
Xiaohui Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation
XH Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Catalytic independent functions of a protein kinase as revealed by a kinase-dead mutant: Study of the Lys72His mutant of cAMP-dependent kinase
GH Iyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain
P Saharinen et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction
P Saharinen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evolutionary analysis for functional divergence of Jak protein kinase domains and tissue-specific genes
JY Gu et al.
JOURNAL OF MOLECULAR EVOLUTION (2002)
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling
TC Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
P Saharinen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains
M Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
